Novaplex SRL
Novaplex reported total assets of 119,122 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Aug 2026).
The score of Novaplex shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Novaplex's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Aug 2026
- Year ended 31 Dec 2024filed on 31 Aug 2025
Novaplex's financial analysis
- Solvency77.1%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Novaplex
Novaplex's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1006.281.364
- VAT number
- BE1006281364
- Peppol
- Registered · 0208:1006281364 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Feb 2024
- Registered office
- 4577 Modave
- Latest accounts
- 2025 · filed on 17 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Novaplex (SRL) has been based in Modave since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 36,666 € and equity of 91,802 €; its revenue is not published. Its solvency stands at 77.1%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Novaplex
Companies in the same business, of comparable size and area, outside its group.
- Wandji Pharma International Manufacture of pharmaceutical preparations Tournai · balance sheet 357,118 €
- Hubert Services Management Retail sale of pharmaceutical products Estinnes · balance sheet 65,144 €
- Codema Pharma Retail sale of pharmaceutical products Brussels · balance sheet 375,959 €
- Lisanne Moons Retail sale of pharmaceutical products Zonhoven · balance sheet 138,433 €
- T.R.F. pharma Retail sale of pharmaceutical products Fléron · balance sheet 70,151 €
- Tannhauser Pharaescos Retail sale of pharmaceutical products Koekelberg · balance sheet 292,153 €
- Quality Pharmaceutical Service Retail sale of pharmaceutical products La Bruyère · balance sheet 110,124 €
- Katrien Smets Retail sale of pharmaceutical products Heist-op-den-Berg · balance sheet 56,328 €
Frequently asked questions about Novaplex
What is the revenue of Novaplex?
Novaplex files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Novaplex?
In Belgium, the VAT number is the company number prefixed with BE: BE1006281364 for Novaplex, if the company is VAT-registered. Its company number (CBE) is 1006.281.364.
Where is the registered office of Novaplex?
According to the CBE register, the registered office of Novaplex is in 4577 Modave.
What is the equity of Novaplex?
At the close of the 2025 financial year, the equity of Novaplex amounts to 91,802 €, a solvency of 77.1% of total assets.
Who manages Novaplex?
The register lists 2 active mandates at Novaplex. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Novaplex
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →